摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-isopropyl-N-(5-isopropyl-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-yl)-acetamide | 56610-91-4

中文名称
——
中文别名
——
英文名称
N-isopropyl-N-(5-isopropyl-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-yl)-acetamide
英文别名
N-(4,6-dioxo-5-propan-2-yl-1H-1,3,5-triazin-2-yl)-N-propan-2-ylacetamide
<i>N</i>-isopropyl-<i>N</i>-(5-isopropyl-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-yl)-acetamide化学式
CAS
56610-91-4
化学式
C11H18N4O3
mdl
——
分子量
254.289
InChiKey
DGNQSSQIJRPIIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    82.1
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Entropic strain and conformational preference in the hydrolysis of some N-alkyl-6-acetylaminotriazinediones
    摘要:
    The rate–pH profiles for hydrolysis of the title compounds 1 show four distinct regions: kA, kB and kC for rate plateaux corresponding to cationic, neutral and anionic species, plus kD for attack of OH- on the anion. At the ends of the pH scale the reaction is much slower than for model amides of comparable pKlg, due to exceptional charge dispersal in reactant and leaving group. The plateau rates kB and kC are due to hydrolysis by water, not to some kinetically equivalent process, and are much faster than model calculations would predict. This is traced to intramolecular general base catalysis via solvent bridges, and leads to remarkable rate enhancements in aqueous alcohols. The considerable, and quite independent, variations in kB, kC and acid pKa with only alkyl substitution in the amide moiety points to a dominant effect of conformation which has been explored using a number of techniques, notably octanol–water partitioning, and appears best rationalised in terms of Taft’s ‘steric hindrance of motions’ or Tillett’s ‘entropic strain’. The overall picture for the effect of pH is of successively increasing C–O bond formation in the transition state along the sequence kA → kB → kC but with C–N bond breaking quite out of line and largely dependent on conformational factors.Given pKcat < 0, the presence of effective intramolecular general base catalysis in kB is unexpected. We explain this as being due to a unique feature of 1 whereby catalyst and leaving group are part of the same conjugated structure, leading to pKcat → pK lg as C–N bond-breaking proceeds. Further light on kB comes from the ring-N-methylated analogue 3d, which cannot form the intramolecular hydrogen bond found elsewhere and whose otherwise similar rate–pH profile shows an anomalous ‘apparent pKa’ that can be explained as a consequence of this.
    DOI:
    10.1039/a700736a
点击查看最新优质反应信息

同类化合物

酪氨酸,2-甲氧基-O-甲基- 达美司特 百里酚-6-磺化三(2-羟基乙基)铵 吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 吡唑并[1,5-a][1,3,5]三嗪-2,4-二胺 吡唑并[1,5-a]-1,3,5-三嗪-4-胺,N-羟基- 吡唑并[1,5-D][1,2,4]三嗪酮 吡唑并[1,5-A]-1,3,5-三嗪-2,4(1H,3H)-二酮 N4-(1,1-二甲基乙基)-7-甲基吡唑并(1,5-a)-1,3,5-三嗪-2,4-二胺盐酸盐 N'-甲酰基-4-氨基吡唑并[5,1-c][1,2,4]三嗪-3-甲酰肼 8-苄基-2-甲基-4-(N-甲基氨基)吡唑并[1,5-a]-1,3,5-三嗪 8-碘-1H,4H-吡唑并[1,5-a][1,3,5]三嗪-4-酮 8-溴-4-氯-2-(甲基硫代)吡唑并[1,5-a][1,3,5]三嗪 8-溴-2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4-醇 8-溴-2,7-二甲基-3H-吡唑并[1,5-a][1,3,5]噻嗪-4-酮 8-溴-1H,4H-吡唑并[1,5-a][1,3,5]三嗪-4-酮 7-甲基-吡唑并[1,5-a]-1,3,5-三嗪-4(1H)-酮 7-甲基-6H-吡唑并[4,5-e][1,2,3]三嗪-4-酮 7-甲基-1,7-二氢-4H-吡唑并[3,4-d][1,2,3]三嗪-4-酮2-氧化物 7-(叔丁基)吡唑并[1,5-a][1,3,5]三嗪-4(3H)-酮 5-二乙基氨基甲基-2-苯基呋喃-3-羧酸 5,6-二氢吡唑并[1,5-d][1,2,4]三嗪-4,7-二酮 4-甲氧基吡唑并[1,5-a][1,3,5]三嗪 4-氯-2-(甲硫基)吡唑并[1,5-a][1,3,5]三嗪 4-氨基-7-甲基吡唑并[5,1-C][1,2,4]三嗪-3-甲腈 4,7-二甲基吡唑并[5,1-c][1,2,4]三嗪-3-羧酸乙酯 4,7-二甲基吡唑并[5,1-C][1,2,4]三嗪-3-羧酸 4,6-二氢-6-(碘乙酰基)-3-甲基-4-亚甲基吡唑并[5,1-c][1,2,4]三嗪 3-甲氧基-2H-吡唑并[4,3-e][1,2,4]三嗪 3-(1,1-二甲基乙基)-7-(5-甲基-3-异恶唑基)-2-[(1-甲基-1H-1,2,4-三唑-5-基)甲氧基]吡唑并[1,5-d][1,2,4]三嗪 3,4-二甲基吡唑并[5,1-c][1,2,4]三嗪 2-甲基吡唑并[1,5-d][1,2,4]三嗪-4(5H)-酮 2-甲基吡唑并[1,5-a][1,3,5]三嗪-4(1H)-酮 2-甲基-4-(N-甲基氨基)-8-[(2-噻吩基)甲基]吡唑并[1,5-a]-1,3,5-三嗪 2-氨基吡唑并[1,5-a][1,3,5]三嗪-4(1H)-酮 2-Thi氧代-2,3-二氢吡唑并[1,5-a][1,3,5]噻嗪-4(1H)-酮 2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 2,4-二氨基-吡唑并(1,5-a)-S-三嗪盐酸盐半水合物 2,4-二(甲基氨基)-7-甲基吡唑并(1,5-a)-S-三嗪 1-(4,7-二甲基吡唑并[5,1-c][1,2,4]三氮杂-3-基)-1-乙酮 4-chloro-2-methylpyrazolo[1,5-a][1,3,5]triazine 8,9-Bis-(2-furyl)furo<3,2-d>-s-triazolo<4,3-c>pyrimidin N,N-dimethyl-N'-[7-methyl-3-(5-nitro-furan-2-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-formamidine (8-chloro-7-methyl-pyrazolo[1,5-a][1,3,5]triazin-4-yl)-methyl-amine methyl-phosphonothioic acid O-isopropyl ester O'-{1-[6-oxo-4-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-1,6-dihydro-pyridazin-3-yl} ester 9-bromo-3-phenyl-pyridazino[1,6-a][1,3,5]triazine-2,4-dione prop-2-ynyl 5-(1H-benzo[d][1,2,3]triazol-5-yl)-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbimidate hydrochloride 6-Acetyl-3-methyl-4-methylen-pyrazolo<3,2-c>-as-triazin 2-Methylamino-5,7-dimethyl-s-triazolo<2,3-c>pyrimidin ethyl 7-benzamido-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carboxylate